Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Turning Point Therapeutics
Biotech
Sands Capital raises new $555M life sci fund
Sands Capital's 2024 therapeutic investments include BioAge Labs and Avenzo Therapeutics.
Max Bayer
May 14, 2024 10:30am
Geopolitics threatens Chinese biotechs' hot out-licensing biz
Apr 11, 2024 4:00am
A new biotech blooms with $100M to take on small molecules
Feb 29, 2024 9:30am
BMS strikes up Roche rivalry with $4.1B Turning Point buy
Jun 3, 2022 9:01am
Lengo's hiring spree continues with Pfizer vet
Nov 1, 2021 9:30am
Turning Point posts data on Rozlytrek rival
Aug 20, 2020 9:15am
